Mar. 29, 2023

SEQ-9

oral Mtb 23S bacterial ribosome inhibitor potent in vitro + in vivo activity against Mycobacterium tuberculosis opt. of sequanamycin macrolides Cell, February 23, 2023 Sanofi, FR +CH

drughunter.com
Drug Hunter Team
Loading...

twitterlinkedinemail

Other molecules you may be interested in